Cognitive Impairment and Cerebral Haemodynamics in Individuals With Symptomatic Peripheral Arterial Disease

Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY

Background: Arterial disease of the legs causes symptoms such as pain when walking and may ultimately lead to a leg amputation. Many older people with arterial disease of the legs also have problems with their thinking and memory. Blood flow in the brain may be altered in these people and may be a cause for memory and thinking problems. Aim: The aim of this project is to investigate whether people with arterial disease of the legs have altered blood flow in the brain causing problems with memory and thinking. Research plan: Twenty people with arterial disease of the legs causing pain while walking and twenty healthy people will have a series of non-invasive assessments. Arterial disease in the legs will be measured using ankle blood pressures before and after walking. Blood flow in the brain will be measured using ultrasound whilst performing memory and thinking tests. Results will be compared between the people with arterial disease in the legs and the healthy people to see if there are any differences in blood flow to the brain and memory and thinking. Benefits to society: This project will help determine if there is a link between arterial disease of the legs and memory and thinking problems caused by altered blood flow in the brain. It will enable future research in people with cognitive impairment caused by altered blood supply to the brain and to prevent confusion and further memory and thinking problems in people undergoing surgery for arterial disease of the legs.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
View:

• Capacity to provide Informed volunteer/patient consent

• Male or female, aged ≥50 years of age

• Able (in the Investigator's opinion) and willing to comply with all study requirements

• Good understanding of written and verbal English

⁃ Peripheral arterial disease specific inclusion criteria:

• Clinical diagnosis of symptomatic PAD (intermittent claudication) confirmed by positive haemodynamic tests (ABPI \<0.90 in the symptomatic leg; and/or,

• Post-exercise \[walk test\] reduction in ABPI of \>20% or post-exercise \[walk test\] reduction in absolute ankle pressure of \>30mmHg)

Locations
Other Locations
United Kingdom
Glenfield Hospital Leicester
RECRUITING
Leicester
Contact Information
Primary
John SM Houghton
jsmh2@le.ac.uk
+44 (0)116 2502645
Backup
Tanya J Payne
tjp28@le.ac.uk
+44 (0)116 2502645
Time Frame
Start Date: 2024-05-22
Estimated Completion Date: 2025-07-31
Participants
Target number of participants: 40
Treatments
Individuals with symptomatic peripheral arterial disease
Individuals with intermittent claudication caused by confirmed peripheral arterial disease defined as a resting ankle-brachial pressure index of \<0.9 and/or a post-exercise reduction in either ankle-brachial pressure index of \>20% or absolute ankle pressure of \>30mmHg.
Healthy controls
Age- and sex-matched cohort of individuals without peripheral arterial disease.
Sponsors
Leads: University of Leicester
Collaborators: University Hospitals, Leicester

This content was sourced from clinicaltrials.gov